Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 67,028 shares at $150.00 ($10.1M) on 2025-07-16, disclosed to the SEC on 2025-07-16.
Scheduled sale ($10.1M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.29 | 13,335 | $2.0M | 19.9% |
| 2 | $150.29 | 13,335 | $2.0M | 19.9% |
| 3 | $150.30 | 13,400 | $2.0M | 20.0% |
| 4 | $150.30 | 13,400 | $2.0M | 20.0% |
| 5 | $151.00 | 100 | $15K | 0.1% |
| 6 | $150.68 | 2,184 |
| $329K |
| 3.3% |
| 7 | $150.68 | 2,236 | $337K | 3.3% |
| 8 | $150.68 | 2,184 | $329K | 3.3% |
| 9 | $150.68 | 2,236 | $337K | 3.3% |
| 10 | $151.79 | 900 | $137K | 1.4% |
| 11 | $151.79 | 800 | $121K | 1.2% |
| 12 | $150.00 | 1,389 | $208K | 2.1% |
| 13 | $150.00 | 1,529 | $229K | 2.3% |
| Total | $150.37 avg | 67,028 | $10.1M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-11 | $4.0M | — | Filing → |